Clinical Trial Update: Iron Replacement to Reduce Anemia During Neoadjuvant Chemotherapy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating whether iron replacement can reduce anemia in patients undergoing neoadjuvant chemotherapy. Recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia

Drugs mentioned

• Iron replacement therapy

Snippet

Sponsor: Fox Chase Cancer Center | Conditions: Anemia | Phase 2 | Status: RECRUITING